ICW Investment Advisors LLC Has $1.75 Million Stock Position in Stryker Co. (NYSE:SYK)

ICW Investment Advisors LLC increased its position in shares of Stryker Co. (NYSE:SYK) by 0.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,846 shares of the medical technology company’s stock after buying an additional 30 shares during the quarter. ICW Investment Advisors LLC’s holdings in Stryker were worth $1,745,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in SYK. Eagle Asset Management Inc. raised its stake in Stryker by 7.4% during the 3rd quarter. Eagle Asset Management Inc. now owns 23,856 shares of the medical technology company’s stock worth $8,969,000 after buying an additional 1,647 shares during the period. Meridian Wealth Management LLC acquired a new position in Stryker during the 3rd quarter worth approximately $665,000. Nwam LLC bought a new stake in Stryker during the 3rd quarter worth approximately $1,046,000. Kingsview Wealth Management LLC increased its holdings in Stryker by 0.9% during the 3rd quarter. Kingsview Wealth Management LLC now owns 14,118 shares of the medical technology company’s stock worth $5,100,000 after purchasing an additional 124 shares in the last quarter. Finally, Swedbank AB increased its holdings in Stryker by 10.9% during the 3rd quarter. Swedbank AB now owns 51,070 shares of the medical technology company’s stock worth $18,450,000 after purchasing an additional 5,032 shares in the last quarter. 77.09% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have commented on SYK. Argus set a $450.00 price objective on Stryker in a report on Monday, February 3rd. Needham & Company LLC reissued a “buy” rating and set a $442.00 price objective on shares of Stryker in a report on Friday. Royal Bank of Canada boosted their price objective on Stryker from $425.00 to $435.00 and gave the stock an “outperform” rating in a report on Wednesday, January 29th. Morgan Stanley raised Stryker from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $370.00 to $445.00 in a report on Monday, December 2nd. Finally, Wells Fargo & Company upped their target price on Stryker from $427.00 to $435.00 and gave the company an “overweight” rating in a report on Wednesday, January 29th. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $421.90.

Insider Activity

In other news, Director Allan C. Golston sold 2,458 shares of the company’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total transaction of $941,586.06. Following the sale, the director now directly owns 14,895 shares in the company, valued at approximately $5,705,827.65. This represents a 14.16 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Ronda E. Stryker sold 201,392 shares of the company’s stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the transaction, the director now owns 3,642,075 shares in the company, valued at $1,428,567,498. The trade was a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 5.90% of the company’s stock.

Stryker Stock Down 0.8 %

Shares of NYSE:SYK opened at $371.38 on Monday. The stock’s 50-day moving average price is $384.28 and its 200-day moving average price is $374.12. Stryker Co. has a 12-month low of $314.93 and a 12-month high of $406.19. The stock has a market capitalization of $141.71 billion, a P/E ratio of 47.86, a price-to-earnings-growth ratio of 2.93 and a beta of 0.95. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 0.59.

Stryker (NYSE:SYK) last posted its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same period in the previous year, the firm earned $3.46 EPS. On average, equities analysts anticipate that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 0.90%. The ex-dividend date is Monday, March 31st. Stryker’s dividend payout ratio (DPR) is presently 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.